176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-19.11%
Negative revenue growth while AMD stands at 0.11%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-46.33%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-73.29%
Negative EBIT growth while AMD is at 125.49%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-73.29%
Negative operating income growth while AMD is at 86.21%. Joel Greenblatt would press for urgent turnaround measures.
-59.46%
Negative net income growth while AMD stands at 119.42%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-60.00%
Negative EPS growth while AMD is at 122.22%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-59.38%
Negative diluted EPS growth while AMD is at 122.22%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.44%
Share reduction while AMD is at 4.38%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.83%
Reduced diluted shares while AMD is at 0.99%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.44%
Dividend growth of 0.44% while AMD is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-26.63%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-38.91%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
537.09%
10Y revenue/share CAGR above 1.5x AMD's 111.89%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
187.74%
5Y revenue/share CAGR above 1.5x AMD's 98.34%. David Dodd would look for consistent product or market expansions fueling outperformance.
153.80%
3Y revenue/share CAGR 1.25-1.5x AMD's 107.17%. Bruce Berkowitz might see better product or regional expansions than the competitor.
527.38%
10Y OCF/share CAGR at 75-90% of AMD's 597.08%. Bill Ackman would demand strategic changes to close the gap in long-term cash generation.
72.42%
Below 50% of AMD's 647.36%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
32.48%
3Y OCF/share CAGR above 1.5x AMD's 16.49%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
446.85%
Net income/share CAGR above 1.5x AMD's 116.75% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
7.70%
Positive 5Y CAGR while AMD is negative. John Neff might view this as a strong mid-term relative advantage.
16.03%
Positive short-term CAGR while AMD is negative. John Neff would see a clear advantage in near-term profit trajectory.
431.45%
Below 50% of AMD's 6950.14%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
282.19%
Below 50% of AMD's 3976.54%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
125.30%
Below 50% of AMD's 1145.99%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
13.94%
Dividend/share CAGR of 13.94% while AMD is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
-0.37%
Negative near-term dividend growth while AMD invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-2.23%
Firm’s AR is declining while AMD shows 6.73%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
22.95%
Inventory growth well above AMD's 7.84%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-3.84%
Negative asset growth while AMD invests at 0.49%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-8.98%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-0.06%
We’re deleveraging while AMD stands at 0.42%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
12.73%
R&D growth drastically higher vs. AMD's 2.27%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
No Data
No Data available this quarter, please select a different quarter.